GMO Quality V (GQLFX)

22.48 +0.01  +0.04% Feb 26 USD
View Full Chart
Total Returns Chart

Key Stats

Net Asset Value 22.48
Turnover Ratio 18.00%
1 Year Fund Level Flows -675.26M

Performance & Returns

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M -- 1.32% 21
3M -- 5.06% 79
6M -- 8.59% 25
YTD -- 25.10% 85
1Y -- 19.19% 8
3Y -- 11.77% 3
5Y -- 9.52% 1
10Y -- 11.89% 57
15Y -- 8.09% --
20Y -- 5.99% --
As of Feb. 26, 2019. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 0.43% 0.43% 0.00%
Stock 97.07% 97.07% 0.00%
Bond 2.06% 2.06% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.44% 0.46% 0.02%
As of Aug. 31, 2019

Region Exposure

Americas 84.69%
North America 84.69%
Latin America 0.00%
Greater Europe 12.85%
United Kingdom 4.50%
Europe Developed 8.35%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 2.46%
Japan 0.00%
Australasia 0.00%
Asia Developed 2.46%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.00%
% Emerging Markets 0.92%
As of Aug. 31, 2019. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 3.15%
Communication Services 0.00%
Consumer Cyclical 5.76%
Consumer Defensive 11.41%
Energy 0.00%
Financial Services 8.58%
Healthcare 24.90%
Industrials 5.39%
Real Estate 0.00%
Technology 40.80%
Utilities 0.00%
As of Aug. 31, 2019

Stock Market Capitalization

Giant 82.09%
Large 17.91%
Medium 0.00%
Small 0.00%
Micro 0.00%
As of Aug. 31, 2019

Stock Style Exposure

Large Cap Value 13.94%
Large Cap Blend 50.42%
Large Cap Growth 35.64%
Mid Cap Value 0.00%
Mid Cap Blend 0.00%
Mid Cap Growth 0.00%
Small Cap Value 0.00%
Small Cap Blend 0.00%
Small Cap Growth 0.00%
As of Aug. 31, 2019
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
MSFT Microsoft Corp 6.20% 153.34 +1.08%
GOOG Alphabet Inc Class C 6.06% 1350.00 +0.37%
AAPL Apple Inc 4.97% 271.65 +0.32%
ORCL Oracle Corp 4.56% 54.71 -2.84%
UNH UnitedHealth Group Inc 3.75% 283.60 +1.11%
MDT Medtronic PLC 3.64% 112.91 +1.07%
ACN Accenture PLC Class A 3.58% 204.99 +1.33%
MRK Merck & Co Inc 3.31% 89.75 +0.87%
WFC Wells Fargo & Co 3.11% 54.30 +2.13%
ROG Roche Holding AG Dividend Right Cert. 3.09% -- --
As of Aug. 31, 2019
Advertisement

Basic Info

Investment Strategy
The investment seeks total return. The fund is permitted to invest directly and indirectly (e.g., through underlying funds or derivatives) in equities of companies tied economically to any country in the world, including emerging countries. The term "equities" refers to direct and indirect investments in common and preferred stocks and other stock-related securities, such as convertible securities, depositary receipts, and equity real estate investment trusts (REITs) and income trusts. It is non-diversified.
General
Security Type Mutual Fund
Oldest Share Symbol GQEFX
Equity Style Large Cap/Growth
Fixed Income Style --
Broad Asset Class US Equity
Broad Category Equity
Category Name Large Blend
Prospectus Objective Growth
Fund Owner Firm Name GMO
Benchmark Index
S&P 500 TR USD 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
Anthony Hene 3.92 yrs
Thomas Hancock 10.45 yrs
Ty Cobb 0.17 yrs

Share Classes

Symbol Share Class
GQEFX Other
GQESX Retirement
GQETX Other
GQLIX Inst
GQLOX Other

Net Fund Flows

1M 62.39M
3M -219.94M
6M -385.44M
YTD -667.26M
1Y -675.26M
3Y -5.285B
5Y -8.352B
10Y -20.26B
As of Nov. 30, 2019

Risk Info

Beta (5Y) --
Historical Sharpe Ratio (10Y) --
Historical Sortino (All) --
Daily Value at Risk (VaR) 1% (All) --
Monthly Value at Risk (VaR) 1% (All) --

Fundamentals

Dividend Yield TTM --
30-Day SEC Yield --
7-Day SEC Yield --
Weighted Average PE Ratio 21.14
Weighted Average Price to Sales Ratio 3.018
Weighted Average Price to Book Ratio 5.182
Weighted Median ROE 33.68%
Weighted Median ROA 12.16%
Forecasted Dividend Yield 1.92%
Forecasted PE Ratio 18.99
Forecasted Price to Sales Ratio 2.947
Forecasted Price to Book Ratio 5.014
Number of Holdings 50
As of Aug. 31, 2019

Growth Estimates

Forecasted 5 Yr Earnings Growth 10.40%
Forecasted Book Value Growth 3.11%
Forecasted Cash Flow Growth 8.55%
Forecasted Earnings Growth 19.85%
Forecasted Revenue Growth 8.62%
As of Aug. 31, 2019

Comparables

Edit

Attributes

Purchase Details
Open to New Investors Yes
Open to Existing Investors Yes
Minimum Initial Investment 250.00M USD
Minimum Subsequent Investment 0.00 USD
Fees
Actual 12B-1 Fee --
Actual Management Fee 0.42%
Administration Fee --
Performance Fee --
Switching Fee --
Transaction Fee --
Maximum Front Load --
Maximum Deferred Load --
Maximum Redemption Fee --
Key Dates
Inception Date 12/8/2006
Termination Date
Last Annual Report Date 2/28/2019
Last Prospectus Date 6/30/2019
Attributes
Exchange Traded Share No
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund No
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund Yes
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.